Navigation Links
Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection with Approved Guidelines
Date:6/13/2008

CHAPEL HILL, N.C., June 13 /PRNewswire/ -- Best Practices, LLC's latest benchmarking study explains how U.S. pharmaceutical and biotechnology organizations can optimize their CI operations while working within defined guidelines.

Particular attention is paid to CI information sources, what is being collected, and how CI groups work within legal groups to develop standard operating procedures for data collection that are in the best interests of the organization as a whole and to maximize the CI department's ability to deliver results.

Savvy CI leaders employ multiple, even overlapping, secondary data sources and triangulate from them to develop the most accurate information and projections, described in the newly published study, "Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection with Approved Guidelines" by Best Practices, LLC. Click here for complimentary download: http://www3.best-in-class.com/dr316.htm

Executives from many of the top 50 pharmaceutical companies have found that one of the most useful tools that they have at their disposal when it comes to gaining information and benchmarking best practices about competitive intelligence is the Best Practices Database. To view a list of just some of the documents pertaining to competitive intelligence click on this link: http://www3.best-in-class.com/dr316.htm

Best Practices Database covers many key functionality areas pertaining to Pharma Industry such as:
-- Resources and strategies required to gain crucial market access

-- Creating blockbusters in an increasingly competitive marketplace

-- Publications strategies that give credibility and increase reputation

-- Key to building effective brand teams

-- Case studies for successful re-launches

-- Strategies for successful structure and roles in launch processes

Top 3 reasons identified by Best Practices, LLC to sign-up for a database tours are:
1. Gather industry-specific Competitive Intelligence

2. Learn Best Practices and use them for yours and your company's growth

3. Gather information to train your staff for proficiency and efficiency

To have a better understanding of Best Practices Database, sign-up for a complimentary tour by clicking here: http://www3.best-in-class.com/dw212.htm

For more information on Best Practices, LLC's products and services please contact Robert Naylor, Senior Research Analyst, Best Practices, LLC at 919-767-9244 or rnaylor@best-in-class.com

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Specializing in best-in-class benchmarking research, Best Practices, LLC probes critical issues that drive organizational impact, influence and efficiency. From facilitating peer-to-peer networking and conducting customized benchmarking research to providing on-demand best practices, Best Practices, LLC offers solutions for all your benchmarking needs.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or ... Congress ("ILC") 2017 of the European Association for the Study ... on the positive effects of PBI-4050 on reduction of non-alcoholic ... syndrome. ... Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This extensive ...
(Date:4/20/2017)... Minneapolis, MN and Bethesda, MD (PRWEB) , ... ... ... for Advancing Innovation announce the formation of a unique intellectual property (IP) sharing ... commercialization potential of their most promising inventions. A main component of this effort ...
(Date:4/20/2017)... April 20, 2017 For today, Stock-Callers.com ... novel drug development and clinical research aimed at treating diseases ... (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. ... ). You can access our complimentary research reports on these ... ...
(Date:4/19/2017)... ... April 18, 2017 , ... Alisa Wright, founder and CEO of Singota ... College of Pharmacy in Lafayette, Indiana. , The Distinguished Alumni Award was established ... careers and other scientific endeavors. , Wright began her career in the pharmaceutical ...
Breaking Biology Technology:
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... its 2016 Annual Report on Form 10-K on Thursday April 13, ... ... the Investor Relations section of the Company,s website at http://www.nxt-id.com ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... According to a new market research report "Consumer ... Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - ... to grow from USD 14.30 Billion in 2017 to USD 31.75 Billion ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):